Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Phase 2 Recruiting 20 enrolled Innovaderm Research Inc.

RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a single-blind, intraindividual study to evaluate the efficacy of ruxolitinib 1.5 % cream in adult subjects with discoid lupus erythematosus.

Timeline

Start: 2024-04-19
Primary completion: 2026-02-28
Completion: 2026-02-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ruxolitinib	Small molecule	1.5 %	Topical

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Summary

Timeline

Drugs

Indications